Impact of Acute Methotrexate-Induced Neurotoxicity on Therapy Among Pediatric Patients with Acute Lymphoblastic Leukemia

被引:0
|
作者
Danysh, H. [1 ]
Brown, A. [1 ]
Taylor, O. [1 ]
Brackett, J. [1 ]
Lupo, P. [1 ]
Moore, I. [2 ]
Hooke, M. C. [3 ]
Hockenberry, M. [4 ]
Scheurer, M. [1 ]
机构
[1] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA
[2] Univ Arizona, Coll Nursing, Tucson, AZ 85721 USA
[3] Univ Minnesota, Sch Nursing, Minneapolis, MN 55455 USA
[4] Duke Univ, Sch Nursing, Durham, NC 27708 USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
P-536
引用
收藏
页码:S410 / S410
页数:1
相关论文
共 50 条
  • [31] Neurocognitive Performance Among Survivors of Pediatirc Acute Lymphoblastic Leukemia (ALL) With and Without a History of Acute Methotrexate Neurotoxicity
    Taylor, O.
    Raghubar, K.
    Woodhouse, J.
    Barrow, M.
    Bernhardt, B.
    Dreyer, Z.
    Brackett, J.
    Scheurer, M.
    Brown, A.
    PEDIATRIC BLOOD & CANCER, 2020, 67 : S8 - S8
  • [32] Predictors of methotrexate-induced toxicity and treatment outcome in patients with acute lymphoblastic leukemia treated with EORTC 58951 protocol
    Ben Mahmoud, L.
    Mdhaffar, M.
    Ammar, M.
    Ghozzi, H.
    Ahmed, H.
    Zouheir, S.
    Elloumi, M.
    Zeghal, K.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2017, 31 : 71 - 71
  • [33] The influence of MTHFR genetic polymorphisms on methotrexate therapy in pediatric acute lymphoblastic leukemia
    Shen, Yaqing
    Wang, Zhujun
    Zhou, Fen
    Jin, Runming
    OPEN LIFE SCIENCES, 2021, 16 (01): : 1203 - 1212
  • [34] High-Dose Methotrexate-Induced Idiopathic Intracranial Hypertension in Infant Acute Lymphoblastic Leukemia
    Zhang, Yazhi
    Qiu, Yining
    Wang, Zhujun
    Wang, Ran
    Jin, Runming
    Hinkle, Louis Edward
    Wu, Xiaoyan
    FRONTIERS IN PHARMACOLOGY, 2020, 11
  • [35] Evaluation of methotrexate Pharmacogenomic variation to predict acute neurotoxicity in children with acute lymphoblastic leukemia
    Harris, Rachel D.
    Taylor, Olga A.
    Gramatges, M. Monica
    Hughes, Amy E.
    Zobeck, Mark
    Pruitt, Sandi
    Bernhardt, M. Brooke
    Chavana, Ashley
    Huynh, Van
    Ludwig, Kathleen
    Klesse, Laura
    Heym, Kenneth
    Griffin, Timothy
    Erana, Rodrigo
    Bernini, Juan Carlos
    Choi, Ashley
    Ohno, Yuu
    Richard, Melissa A.
    Morrison, Alanna C.
    Chen, Han
    Yu, Bing
    Lupo, Philip J.
    Rabin, Karen
    Scheurer, Michael E.
    Brown, Austin L.
    PHARMACOTHERAPY, 2025, 45 (01): : 4 - 11
  • [36] Medium and high-dose methotrexate-induced toxicity in children with acute lymphoblastic leukemia (ALL)
    Hedavatiasl, Amirabas
    Darbandi, Bahram
    Vossough, Parvaneh
    Faranoush, Mohammad
    Golpayegani, Mohammad Reza
    Zangooie, Rokhsaneh
    Yazdi, Fatemeh
    Rafsanjani, Khadijeh Arjmandi
    Ansari, Shahla
    Zarrabi, Mohammad
    PEDIATRIC BLOOD & CANCER, 2007, 49 (04) : 490 - 491
  • [37] Folate pathway genetic polymorphisms modulate methotrexate-induced toxicity in childhood acute lymphoblastic leukemia
    Yousef, Al-Motassem
    Farhad, Rand
    Alshamaseen, Daniah
    Alsheikh, Abrar
    Zawiah, Mohammed
    Kadi, Taha
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2019, 83 (04) : 755 - 762
  • [38] Folate pathway genetic polymorphisms modulate methotrexate-induced toxicity in childhood acute lymphoblastic leukemia
    Al-Motassem Yousef
    Rand Farhad
    Daniah Alshamaseen
    Abrar Alsheikh
    Mohammed Zawiah
    Taha Kadi
    Cancer Chemotherapy and Pharmacology, 2019, 83 : 755 - 762
  • [39] Methotrexate-Induced Subacute Combined Degeneration in Acute Lymphoblastic Leukemia with CNS Relapse May Be Reversible
    Dukenik, David Bared
    Soong, Deborah
    Li, Wenhui
    Madarang, Ellen
    Watts, Justin
    Taylor, Justin
    HEMATO, 2023, 4 (04): : 311 - 320
  • [40] GENETIC AND METABOLIC DETERMINANTS OF METHOTREXATE INDUCED MUCOSITIS IN PEDIATRIC ACUTE LYMPHOBLASTIC LEUKEMIA
    den Hoed, M.
    Lopez-Lopez, E.
    te Winkel, M. L.
    Tissing, W.
    de Rooij, J. D. E.
    Gutierrez-Camino, A.
    Garcia-Orad, A.
    den Boer, E.
    Pieters, R.
    Pluijm, S. M. F.
    de Jonge, R.
    van den Heuvel-Eibrink, M. M.
    PEDIATRIC BLOOD & CANCER, 2014, 61 : S140 - S141